Results
|
|
1621.
|
|
|
|
1622.
|
|
|
|
1623.
|
|
|
|
1624.
|
|
|
|
1625.
|
Overexpression of gastrin and c-met protein involved in human gastric carcinomas and intestinal metaplasia. [electronic resource] by
- Tang, Zhuobin
- Zhao, Min
- Ji, Jiafu
- Yang, Guibin
- Hu, Fulian
- He, Jingsheng
- Shen, Hui
- Gao, Zhian
- Zhao, Ailian
- Li, Jiyou
- Lu, Youyong
Producer: 20040803
In:
Oncology reports vol. 11
Availability: No items available.
|
|
|
1626.
|
|
|
|
1627.
|
|
|
|
1628.
|
|
|
|
1629.
|
|
|
|
1630.
|
|
|
|
1631.
|
|
|
|
1632.
|
|
|
|
1633.
|
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. [electronic resource] by
- Trovato, Maria
- Torre, Maria Luisa
- Ragonese, Marta
- Simone, Angela
- Scarfì, Rosy
- Barresi, Valeria
- Giuffrè, Giuseppe
- Benvenga, Salvatore
- Angileri, Flavio F
- Tuccari, Giovanni
- Trimarchi, Francesco
- Ruggeri, Rosaria Maddalena
- Cannavò, Salvatore
Producer: 20140731
In:
Endocrine vol. 44
Availability: No items available.
|
|
|
1634.
|
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. [electronic resource] by
- Wallace, Gerald C
- Dixon-Mah, Yaenette N
- Vandergrift, W Alex
- Ray, Swapan K
- Haar, Catherine P
- Mittendorf, Amber M
- Patel, Sunil J
- Banik, Naren L
- Giglio, Pierre
- Das, Arabinda
Producer: 20140224
In:
Metabolic brain disease vol. 28
Availability: No items available.
|
|
|
1635.
|
|
|
|
1636.
|
The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme. [electronic resource] by
- Olmez, O F
- Cubukcu, E
- Evrensel, T
- Kurt, M
- Avci, N
- Tolunay, S
- Bekar, A
- Deligonul, A
- Hartavi, M
- Alkis, N
- Manavoglu, O
Producer: 20141009
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 16
Availability: No items available.
|
|
|
1637.
|
Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors. [electronic resource] by
- Zhao, Yanmei
- Zhang, Jiankang
- Zhuang, Rangxiao
- He, Ruoyu
- Xi, Jianjun
- Pan, Xuwang
- Shao, Yidan
- Pan, Jinming
- Sun, Jingjing
- Cai, Zhaobin
- Liu, Shourong
- Huang, Weiwei
- Lv, Xiaoqing
Producer: 20170801
In:
Bioorganic & medicinal chemistry vol. 25
Availability: No items available.
|
|
|
1638.
|
The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review. [electronic resource] by
- Chen, Shouzhen
- Zhu, Yaofeng
- Cui, Jianfeng
- Wang, Yong
- Xia, Yangyang
- Song, Jing
- Cheng, Shanshan
- Zhou, Changkuo
- Zhang, Dongqing
- Zhang, Bing
- Shi, Benkang
Producer: 20180509
In:
Urologic oncology vol. 35
Availability: No items available.
|
|
|
1639.
|
MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer. [electronic resource] by
- Zheng, Difan
- Wang, Rui
- Ye, Ting
- Yu, Su
- Hu, Haichuan
- Shen, Xuxia
- Li, Yuan
- Ji, Hongbin
- Sun, Yihua
- Chen, Haiquan
Producer: 20180116
In:
Oncotarget vol. 7
Availability: No items available.
|
|
|
1640.
|
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer. [electronic resource] by
- Lee, Jeeyun
- Kim, Seung Tae
- Park, Sungju
- Lee, Sujin
- Park, Se Hoon
- Park, Joon Oh
- Lim, Ho Yeong
- Ahn, Hongmo
- Bok, Haesook
- Kim, Kyoung-Mee
- Ahn, Myung Ju
- Kang, Won Ki
- Park, Young Suk
Producer: 20190401
In:
Clinical colorectal cancer vol. 17
Availability: No items available.
|